EMCDDA publications: archives
Medical use of cannabis
04.12.2018 - EMCDDA's first report on this topic, as more European countries develop policies and practice in this area.
Drug use in recreational settings
15.11.2018 - A new EMCDDA report deals with monitoring drug use in recreational settings and ways to build a picture of this phenomenon.
Today's captagon illicit market
Two new opioïds under control across the EU
28.09.2018 - two fentanyl-related substances, cyclopropylfentanyl and methoxyacetylfentanyl, have been placed under control across the EU.
New psychoactive substances in prison
07.06.2018 - Preliminary analysis of a ‘trendspotter’ study carried out by the EMCDDA in 2017.
Drug-related homicide in Europe
25.05.2018 - The EMCDDA releases a paper providing an overview of the information available on drug-related homicide (DRH) in Europe.
Cannabis and driving : briefing for policy making
23.05.2018 - This briefing aims to provide those concerned with policy in this field.
Two cannabinoids under control in the EU
14.05.2018 - the Council of the EU has decided to subject ADB-CHMINACA and CUMYL-4CN-BINACA to control measures.
Wastewater analysis in 56 european towns
07.03.2018 - Findings of the largest European project to date presented today by the Europe-wide SCORE group, in association with the EMCDDA.
EMCDDA-Europol Joint Reports on 2 new opioids
Drug supply monitoring
07.12.2017 - The EMCDDA presents in a new paper its current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction.
Drugs and the darknet
28.11.2017 - The EMCDDA and Europol present the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond.
Drug testing in schools
22.11.2017 - This EMCDDA paper (17 p.) evaluates the effectiveness of random testing in schools, based on studies conducted students aged 13 to 19 years, in the United States.
Furanylfentanyl under control across the EU
15.11.2017 - the EU has decided to subject the new synthetic opioid to control measures. Member States will have one year to introduce them into national legislation.
EMCDDA-Europol Joint Report on carfentanyl
13.11.2017 - See the joint report published by the 2 organizations in accordance with Article 5 of the EU Council Decision 2005/387/JHA.
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2018 EMCDDA European Drug Report.
Country drug reports 2018
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.